Cargando…
Hematopoietic stem cell transplantation for multiple sclerosis: is it a clinical reality?
Hematopoietic stem cell transplantation (HSCT) is a treatment paradigm that has long been utilized for cancers of the blood and bone marrow but has gained some traction as a treatment paradigm for multiple sclerosis (MS). Success in the treatment of patients with this approach has been reported prim...
Autores principales: | Bakhuraysah, Maha M., Siatskas, Christopher, Petratos, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715306/ https://www.ncbi.nlm.nih.gov/pubmed/26772391 http://dx.doi.org/10.1186/s13287-015-0272-1 |
Ejemplares similares
-
Nogo-Receptor 1 Deficiency Has No Influence on Immune Cell Repertoire or Function during Experimental Autoimmune Encephalomyelitis
por: Litwak, Sara A., et al.
Publicado: (2013) -
The Beta-Amyloid Protein of Alzheimer's Disease: Communication Breakdown by Modifying the Neuronal Cytoskeleton
por: Mokhtar, Sara H., et al.
Publicado: (2013) -
Nogo receptor-Fc delivered by haematopoietic cells enhances neurorepair in a multiple sclerosis model
por: Ye, Sining, et al.
Publicado: (2023) -
Feasibility and toxicity of hematopoietic stem cell transplant in multiple sclerosis
por: Kuan, Thomas Low Tat, et al.
Publicado: (2017) -
Neurotoxicity after hematopoietic stem cell transplant in multiple sclerosis
por: Thebault, Simon, et al.
Publicado: (2020)